Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 075351
Company: NOVITIUM PHARMA
Company: NOVITIUM PHARMA
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE | ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE | 325MG;50MG;40MG;30MG | CAPSULE;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 03/05/1999 | ORIG-1 | Approval |
Review
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/75-351_Butalbital.cfm |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 12/22/2025 | SUPPL-11 | Labeling-Package Insert |
Label is not available on this site. |
||
| 11/21/2024 | SUPPL-10 | Labeling-Package Insert |
Label is not available on this site. |
||
| 04/30/2025 | SUPPL-9 | REMS - MODIFIED - D-N-A |
Label is not available on this site. |
||
| 10/23/2024 | SUPPL-8 | Labeling-Medication Guide, Labeling-Package Insert |
Label is not available on this site. |
||
| 12/15/2023 | SUPPL-7 | Labeling-Medication Guide, Labeling-Package Insert |
Label is not available on this site. |
||
| 12/04/2023 | SUPPL-6 | Labeling-Package Insert |
Label is not available on this site. |
||
| 09/18/2018 | SUPPL-5 | REMS - PROPOSAL - D-N-A |
Label is not available on this site. |
||
| 12/04/2023 | SUPPL-4 | Labeling-Medication Guide, Labeling-Package Insert |
Label is not available on this site. |
||
| 07/18/2002 | SUPPL-2 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
| 06/07/2001 | SUPPL-1 | Manufacturing (CMC)-Control |
Label is not available on this site. |